Search

Search Constraints

You searched for: Author/Creator Roger, Pascal

Search Results

1. Oropharyngeal cancer: First relapse description and prognostic factor of salvage treatment according to p16 status, a GETTEC multicentric study. (January 2021)

2. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. Issue 1 (4th February 2019)

3. Upfront surgery or definitive radiotherapy for patients with p16-negative oropharyngeal squamous cell carcinoma. A GETTEC multicentric study. Issue 2 (February 2021)

4. Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. Issue 5 (18th December 2013)

5. HER2 overexpression a major risk factor for recurrence in pT1a‐bN0M0 breast cancer: results from a French regional cohort. (10th January 2014)

6. Synchronous primary neoplasia in patients with oropharyngeal cancer: Impact of tumor HPV status. A GETTEC multicentric study. (January 2021)

7. Upfront surgery or definitive radiotherapy for p16+ oropharyngeal cancer. A GETTEC multicentric study. Issue 6 (June 2021)

8. HER2 overexpression a major risk factor for recurrence in pT1a‐bN0M0 breast cancer: results from a French regional cohort. (10th January 2014)

9. A deep‐learning algorithm to localize basal cell carcinoma foci on Mohs surgery frozen sections. (24th January 2023)

10. SPARC in cancer‐associated fibroblasts is an independent poor prognostic factor in non‐metastatic triple‐negative breast cancer and exhibits pro‐tumor activity. Issue 6 (30th November 2022)